Showing results (141-150 of 226) with videos related to

Sort By:
Pageof 23
Arthritis and Rheumatism|June 16, 2001
Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptidesS Kerlan-Candon, P Louis-Plence, A Wiedemann, et al.
Annals of the Rheumatic Diseases|February 15, 2011
Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)M Dougados, J Braun, S Szanto, et al.
American Journal of Human Genetics|September 1, 1993
Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesisM H Dizier, J F Eliaou, M C Babron, et al.
Joint Bone Spine|April 25, 2000
Outcomes in patients with incipient undifferentiated arthritisJ Morel, M C Legouffe, M C Bozonat, et al.
The Journal of Rheumatology|June 1, 1990
Anti-F(ab')2 antibody response to the injection of anticlass II HLA alloantibodies in patients with rheumatoid arthritisM Abderrazik, M Moynier, J F Eliaou, et al.
Clinical and Experimental Rheumatology|November 13, 2003
Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot studyT Conrozier, P Bertin, P Mathieu, et al.
Journal of Virology|July 4, 2001
Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structureA Yvon-Groussin, P Mugnier, P Bertin, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluidP Bertin, F Lapicque, E Payan, et al.
The Journal of Rheumatology|July 24, 1998
Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?N Carpentier, P Bertin, P Marquet, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 20, 1998
Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritisJ Debord, N Carpentier, C Sabot, et al.
Pageof 23